Product Image

Contributor Information

  • Name Keith Brown
  • Institute University Of Bristol

Tool Details

  • Tool name: Wilms' tumor 17.94 Cell Line
  • Tool type: Cell Lines
  • Parental cell line:
  • Organism: Human
  • Tissue: Kidney
  • Description: Wilms' tumor 17.94 Cell Line is an anaplastic Wilms' tumor (WT) cell line, which expressed NCAM, SALL1, and phenotypic features expected of metanephric blastema-derived cells. In Brown et al., 2005 treatment of 17.94 cells with 12-O-Tetradecanoylphorbol 13-acetate caused morphological changes, which led to reduced NCAM and SALL1 expression, but expression of vimentin was maintained. Wilms' tumor 17.94 Cell Line contains a TP53 mutation but lacks mutations in WT1, WTX, or CTNNB1, other genes involved in WT pathogenesis. The cells demonstrate no loss of heterozygosity at 7p, 11p, or 16q although DNA hypermethylation was detected at several loci, including the H19 differentially methylated region and at the PCDH@ gene clusters at 5q31.
  • Research area: Cancer

  • For Research Use Only

Target Details

Application Details

Handling

  • Format: Frozen
  • Growth medium: 80% Dulbecco's MEM + 20% h.i. FBS at 37°C with 5% CO2. Seed out at ca. 0.5-1 x 10^6 cells/25 cm2 flask; split semi-confluent culture 1:2 once a week using TrypLE Express.
  • Storage medium: 70% medium, 20% FBS, 10% DMSO
  • Shipping conditions: Dry ice
  • Mycoplasma free: Yes
  • Biosafety level: 1

Documentation

  • Available on request

References

  •   Brown et al. 2012. Cancer Genet. 205(6):319-26. PMID: 22749038.
  •   Characterization of 17.94, a novel anaplastic Wilms' tumor cell line.